CYRAMZA, combined with other medications, is used for the treatment of patients with advanced gastric cancer or GEJ, metastatic non-small cell lung cancer (NSCLC), and metastatic colorectal cancer (mCRC).
Capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for adjuvant colon cancer, metastatic colorectal cancer, and metastatic breast cancer.
LONSURF is a prescription oral medicine indicated for patients with refractory metastatic colorectal cancer (mCRC) who have previously used other treatment options. Please see Important Safety Information and full Prescribing Information.
FoundationOne CDx is the first FDA-approved broad companion diagnostic (CDx) that is clinically and analytically validated for solid tumors
High sensitivity and high compliance in one easy colorectal cancer screening strategy.
Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.
CAMPTOSAR medication page for healthcare professionals to search for scientific information on Pfizer medications. Also find the package insert, announcements, resources, and ways to connect with Pfizer Medical through a variety of channels.
Learn about FDA-cleared CELLSEARCH® Circulating Tumor Cell (CTC) Test for determining the prognosis of patients with metastatic breast, prostate, or colorectal cancer
Find HCP resources for ERBITUX (cetuximab) and download efficacy data and safety information from clinical trials.
Spectrum is committed to helping your patients access KHAPZORY TM
Learn about Avastin® (bevacizumab) for FDA approved indications. Recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer (rOC) Avastin, in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan, is indicated for the treatment of patients with platinum-resistant recurrent epithelial
Xeloda is indicated as a single agent for adjuvant treatment in patients with Dukes’ C colon cancer
ZALTRAP + FOLFIRI is indicated for patients with mCRC that is resistant to or progressed after an oxaliplatin-containing regimen.
Heathcare Professional site for STIVARGA (regorafenib) Tablets. Visit hcp.stivarga-us.com to See Full Safety and Prescribing Information, Including Boxed Warning.
Learn about Vectibix® (panitumumab), a treatment option for wild-type RAS metastatic colorectal cancer. See Prescribing Information and Boxed Warning.
Jan 14th, 2020 - ZIRABEV is a vascular endothelial growth factor inhibitor indicated for the treatment of: Metastatic colorectal cancer, in combination with intravenous fluorouracil-based chemotherapy for first- or second-line treatment. (1.1) Metastatic colorectal cancer, in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy for second-line treatment in patients wh...
Jan 13th, 2020 - LONSURF is a combination of trifluridine, a nucleoside metabolic inhibitor, and tipiracil, a thymidine phosphorylase inhibitor, indicated for the treatment of adult patients with: metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy. (1.1) ...
Jan 8th, 2020 - Oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin, is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. treatment of advanced colorectal cancer. Oxaliplatin Injection is a platinum-based drug used in combination with infusional 5-fluorouracil /leucovorin, which is indicated for: adjuvant t...
Dec 29th, 2019 - Oxaliplatin injection, used in combination with infusional 5-fluorouracil/leucovorin, is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. treatment of advanced colorectal cancer. Oxaliplatin injection is a platinum-based drug used in combination with infusional 5‑fluorouracil /leucovorin, which is indicated for: ...
Dec 29th, 2019 - Capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for: Adjuvant Colon Cancer ( 1.1) Patients with Dukes’ C colon cancer Metastatic Colorectal Cancer ( 1.1) First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred Metastatic Breast Cancer ( 1.2) In combination with docetaxel after failure of prior anthracycline-containing the...